Competitive COMBINED SYNOPSIS (006).pdf

COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE)

Title: Alamar ARGO HT System

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q01157. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a fixed price purchase order to the responsible offeror whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 03/13/2026.

(iv) The associated NAICS code is 334516, and the small business size standard is 1,000 employees.

• This requirement is set aside for small business

(v) Description of Requirement:

ARGO HT instrument must be able to provide the following features:

• Must provide a fully automated, high-throughput proteomics platform capable of processing up to 288 samples per run

• Must provide an integrated qPCR system enabling end-to-end workflow from sample preparation to data output or pooled NGS library generation

• Must provide a total hands-on time of less than 30 minutes with simplified workflow and <5-minute instrument setup

• Must provide results in <6 hours for singleplex assays and <15 hours for multiplex NGS assays

• Must provide cartridge-based reagent system capable of supporting up to three consecutive runs without replacement

• Must provide liquid handling system for automated sample preparation for both qPCR and NGS workflows

• Must provide integrated onboard computing with intuitive user interface for streamlined operation and workflow management

• Must provide a built-in cloud-based primary analysis software (ARGO Command Center) and secondary analysis software (NULISA Analysis Software, NAS)

• Must provide capability to transform raw data into biological insights and publication-ready results through integrated data analysis tools

• Must provide compatibility with ultra-high sensitivity NULISA™ assay technology enabling attomolar-level detection of protein biomarkers

• Must provide scalable multiplexing capability supporting singleplex to high-plex (100s–1000s of targets) biomarker analysis

• Must provide broad sample compatibility including plasma, serum, cerebrospinal fluid (CSF), urine, and cell culture media

• Must provide an application programming interface (API) available for custom method development and instrument control

• Must provide compliance with major regulatory and safety standards including EMC, UL, CE, WEEE, ISO 13485, and ISO 9001

• Must provide operating conditions supporting 15–24°C temperature range and 40–80% non-condensing humidity

• Must provide electrical compatibility with 100–240 V power supply, 50–60 Hz, and maximum power consumption of 1500 watts

• Must provide instrument footprint no larger than 1143 mm (W) × 661 mm (D) × 1016 mm (H) and weight no heavier than 250 kg

• Delivery must be within 90 days from award

(vi) Delivery Location:

National Institutes of Health 6001 Executive Boulevard Rockville, MD 20892

(vii) [Reserved, if needed]

(viii) FAR 52.204-7, System for Award Management, applies to this acquisition.

(ix) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.

(x) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered.

(b) Evaluation Factors: (Customize as needed)

• Price

• Technical capability

• Delivery schedule

(Include relative importance of factors if required.)

(c) A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date.

(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

(xii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices:

“None.”

(xiii) The Defense Priorities and Allocations System (DPAS) is not applicable.

(xiv) Submission Requirements:

Responses must include sufficient information to demonstrate the offeror’s capability to provide the required product or service. Quotes shall include, at a minimum:

• Unit and total price

• Shipping and handling costs

• Delivery timeframe after award

• Delivery terms

• F.O.B. point (destination or origin)

• Product or catalog numbers (if applicable)

• Product/service description

Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.

Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by September 17, 2026, EST) and must reference solicitation number 75N98026Q01157. Responses may be submitted electronically to brian.lind@nih.gov.

(xv) Point of Contact:

Brian Lind Brian.lind@nih.gov